InsiderTrades

Form 4 for PFE Pfizer

Accepted 2025-03-03 00:00:00 ET · period of report 2025-02-27 · accession 0001225208-25-002705 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-03 2025-02-27 PFE LANKLER DOUGLAS M EVP M - OptEx $31.31 +156.9K 309.8K +103% +$4.91M
DM 2025-03-03 2025-02-27 PFE LANKLER DOUGLAS M EVP F - Tax $26.06 -150.6K 306.2K -33% -$3.92M
D 2025-03-03 2025-02-27 PFE LANKLER DOUGLAS M EVP M - OptEx $0.00 -156.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-27 M A 156,914 $31.31 309,790 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
2 Common Common Stock 2025-02-27 F D 146,961 $26.06 159,240 D — — (F3) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F4) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
3 Common Common Stock 2025-02-27 F D 3,589 $26.10 306,201 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
4 Derivative Stock Appreciation Rights 2025-02-27 M D 156,914 $0.00 0 D $31.31 · 2025-02-27 to 2025-02-27 156,914 Common Stock